HopeStage
Back to all studies
RecruitingNCT06073886

Personalized brain stimulation for lasting symptoms after concussion

About this titleRead the official source — NCT06073886
Device studyAges 18–65United StatesPTSD
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Westwood, Los AngelesSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: March 6, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
75
Sponsor
University of California, Los Angeles
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Device
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06073886
Official title
Show the full official title

Personalized Circuit-Based Frontoamygdala Neuromodulation for Persistent Post-Concussive Symptoms

Recruitment & locations

Currently recruiting

Westwood, Los Angeles

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, Los Angeles, a university.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies